"MEDCHEMEXPRESS"
GSK2593074A-98.67% 1 * 10 mg
Supplier: MEDCHEMEXPRESS
GSK2593074A-98.67% 1 * 10 mg
Expand 1 Items
CC-885-CH2-PEG1-NH-CH3 1 * 5 mg
Supplier: MEDCHEMEXPRESS
CC-885-CH2-PEG1-NH-CH3 1 * 5 mg
Expand 1 Items
ADAVOSERTIB (AZD-1775 MK-1775) 1 * 50 mg
Supplier: MEDCHEMEXPRESS
ADAVOSERTIB (AZD-1775 MK-1775) 1 * 50 mg
Expand 1 Items
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO ≥78MG/ML WATER <1MG/ML ETHANOL ≥6MG/ML
ZM 336372 IS A POTENT AND SELECTIV E C-RAF INHIBITOR WITH IC50 OF 70 NM, 10-FOLD SELECTIVITY OVER B-RAF, NO INHIBITION TO PKA/B/C, AMPK, P70S6, ETC.IC50 1 * 1 mL
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO ≥78MG/ML WATER <1MG/ML ETHANOL ≥6MG/ML
ZM 336372 IS A POTENT AND SELECTIV E C-RAF INHIBITOR WITH IC50 OF 70 NM, 10-FOLD SELECTIVITY OVER B-RAF, NO INHIBITION TO PKA/B/C, AMPK, P70S6, ETC.IC50 1 * 1 mL
Expand 1 Items
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO 69 MG/ML WATER <1 MG/ML ETHANOL <1 MG/ML
PFI-1 CAN EFFICIENTLY BLOCK THE INTERACTION OF BET BRDS WITH H3 AND H4 ACETYLATED HISTONE TAILS. IC50 VALUE: 1.89 NM (EC50 FOR THE INHIBITION OF IL6 P 1 * 10 mg
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: DMSO 69 MG/ML WATER <1 MG/ML ETHANOL <1 MG/ML
PFI-1 CAN EFFICIENTLY BLOCK THE INTERACTION OF BET BRDS WITH H3 AND H4 ACETYLATED HISTONE TAILS. IC50 VALUE: 1.89 NM (EC50 FOR THE INHIBITION OF IL6 P 1 * 10 mg
Expand 1 Items
ANTI-MOUSE CD47/IAP ANTIBODY MIAP301 1 * 5 mg
Supplier: MEDCHEMEXPRESS
ANTI-MOUSE CD47/IAP ANTIBODY MIAP301 1 * 5 mg
Expand 1 Items
Trastuzumab emtansine 1 * 1 mg
Supplier: MEDCHEMEXPRESS
Trastuzumab emtansine 1 * 1 mg
Expand 1 Items
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: 10 MM IN DMSO
TRANS-TRANILAST IS AN ANTIALLERGIC DRUG, USED TO TREAT BRONCHIAL A STHMA, ALLERGIC RHINITIS AND ATOPIC DERMATITIS.TARGET: ANGIOTENSIN RECEPTORTRANILAST HAS BEEN APPROVED IN JAPAN AND S 1 * 50 mg
Supplier: MEDCHEMEXPRESS
LIQUID FORMAT IS 10MM*1ML IN DMSO
SOLUBILITY: 10 MM IN DMSO
TRANS-TRANILAST IS AN ANTIALLERGIC DRUG, USED TO TREAT BRONCHIAL A STHMA, ALLERGIC RHINITIS AND ATOPIC DERMATITIS.TARGET: ANGIOTENSIN RECEPTORTRANILAST HAS BEEN APPROVED IN JAPAN AND S 1 * 50 mg